Sarah Tabrizi, PhD, MD - Publications

Affiliations: 
University College London, London, United Kingdom 

200 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ciosi M, Maxwell A, Cumming SA, Hensman Moss DJ, Alshammari AM, Flower MD, Durr A, Leavitt BR, Roos RAC, Holmans P, Jones L, Langbehn DR, Kwak S, ... Tabrizi SJ, et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. Ebiomedicine. PMID 31607598 DOI: 10.1016/j.ebiom.2019.09.020  0.52
2019 Ross CA, Reilmann R, Cardoso F, McCusker EA, Testa CM, Stout JC, Leavitt BR, Pei Z, Landwehrmeyer B, Martinez A, Levey J, Srajer T, Bang J, Tabrizi SJ. Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice. 6: 541-546. PMID 31538087 DOI: 10.1002/mdc3.12808  0.52
2019 Langbehn DR, Stout JC, Gregory S, Mills JA, Durr A, Leavitt BR, Roos RAC, Long JD, Owen G, Johnson HJ, Borowsky B, Craufurd D, Reilmann R, Landwehrmeyer GB, Scahill RI, ... Tabrizi SJ, et al. Association of CAG Repeats With Long-term Progression in Huntington Disease. Jama Neurology. PMID 31403680 DOI: 10.1001/jamaneurol.2019.2368  0.52
2019 Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, et al. Targeting Huntingtin Expression in Patients with Huntington's Disease. The New England Journal of Medicine. PMID 31059641 DOI: 10.1056/NEJMoa1900907  0.36
2019 Osborne-Crowley K, Andrews SC, Labuschagne I, Nair A, Scahill R, Craufurd D, Tabrizi SJ, Stout JC. Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 30767839 DOI: 10.1017/S1355617718001224  0.52
2018 Rowley CD, Tabrizi SJ, Scahill RI, Leavitt BR, Roos RAC, Durr A, Bock NA. Altered Intracortical T-Weighted/T-Weighted Ratio Signal in Huntington's Disease. Frontiers in Neuroscience. 12: 805. PMID 30455625 DOI: 10.3389/fnins.2018.00805  0.52
2018 Andrews SC, Craufurd D, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Stout JC. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease. Neuropsychology. PMID 30211612 DOI: 10.1037/neu0000479  0.52
2018 Baake V, Coppen EM, van Duijn E, Dumas EM, van den Bogaard SJA, Scahill RI, Johnson H, Leavitt B, Durr A, Tabrizi SJ, Craufurd D, Roos RAC. Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study. Neuroimage. Clinical. 19: 66-70. PMID 30035003 DOI: 10.1016/j.nicl.2018.03.033  0.52
2018 Lahr J, Minkova L, Tabrizi SJ, Stout JC, Klöppel S, Scheller E. Working Memory-Related Effective Connectivity in Huntington's Disease Patients. Frontiers in Neurology. 9: 370. PMID 29915555 DOI: 10.3389/fneur.2018.00370  0.52
2018 Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Johnson EB, Durr A, Roos RAC, Leavitt BR, Mills JA, Stout JC, Scahill RI, Tabrizi SJ, Rees G, et al. Testing a longitudinal compensation model in premanifest Huntington's disease. Brain : a Journal of Neurology. PMID 29788038 DOI: 10.1093/brain/awy122  0.52
2018 Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease. Neuroimage. Clinical. 17: 312-324. PMID 29527479 DOI: 10.1016/j.nicl.2017.10.023  0.52
2018 Johnson EB, Byrne LM, Gregory S, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA, Zetterberg H, Tabrizi SJ, Scahill RI, Wild EJ. Neurofilament light protein in blood predicts regional atrophy in Huntington disease. Neurology. PMID 29367444 DOI: 10.1212/WNL.0000000000005005  0.4
2017 Palmer CE, Langbehn D, Tabrizi SJ, Papoutsi M. Test-Retest Reliability of Measures Commonly Used to Measure Striatal Dysfunction across Multiple Testing Sessions: A Longitudinal Study. Frontiers in Psychology. 8: 2363. PMID 29375455 DOI: 10.3389/fpsyg.2017.02363  0.52
2017 Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi SJ. Stimulating neural plasticity with real-time fMRI neurofeedback in Huntington's disease: A proof of concept study. Human Brain Mapping. PMID 29239063 DOI: 10.1002/hbm.23921  0.52
2017 McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, Durr A, Roos RAC, Leavitt BR, Holmans P, Scahill RI, Clark CA, Rees G, Tabrizi SJ. Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes. Biological Psychiatry. PMID 29174593 DOI: 10.1016/j.biopsych.2017.10.019  0.52
2017 Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, ... Tabrizi SJ, et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology. PMID 29142089 DOI: 10.1212/WNL.0000000000004743  0.4
2017 Johnson EB, Gregory S, Johnson HJ, Durr A, Leavitt BR, Roos RA, Rees G, Tabrizi SJ, Scahill RI. Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease. Frontiers in Neurology. 8: 519. PMID 29066997 DOI: 10.3389/fneur.2017.00519  0.4
2017 Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis. Jama Neurology. PMID 28975278 DOI: 10.1001/jamaneurol.2017.2107  0.52
2017 Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C. Design optimization for clinical trials in early-stage manifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906031 DOI: 10.1002/mds.27122  0.52
2017 Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ, Zetterberg H, Langbehn D, Wild EJ. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis. The Lancet. Neurology. PMID 28601473 DOI: 10.1016/S1474-4422(17)30124-2  0.52
2017 McColgan P, Seunarine KK, Gregory S, Razi A, Papoutsi M, Long JD, Mills JA, Johnson E, Durr A, Roos RAC, Leavitt BR, Stout JC, Scahill RI, Clark CA, Rees G, ... Tabrizi SJ, et al. Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease. Jci Insight. 2. PMID 28422761 DOI: 10.1172/jci.insight.92641  0.52
2017 Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Papoutsi M, Mills JA, Durr A, Leavitt BR, Roos RA, Stout JC, Scahill RI, Langbehn DR, Tabrizi SJ, et al. Operationalizing compensation over time in neurodegenerative disease. Brain : a Journal of Neurology. PMID 28334888 DOI: 10.1093/brain/awx022  0.52
2017 McColgan P, Razi A, Gregory S, Seunarine KK, Durr A, A C Roos R, Leavitt BR, Scahill RI, Clark CA, Langbehn DR, Rees G, Tabrizi SJ. Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease. Human Brain Mapping. PMID 28294457 DOI: 10.1002/hbm.23527  0.4
2017 McColgan P, Gregory S, Razi A, Seunarine KK, Gargouri F, Durr A, Roos RA, Leavitt BR, Scahill RI, Clark CA, Tabrizi SJ, Rees G, Coleman A, Decolongon J, et al. White matter predicts functional connectivity in premanifest Huntington's disease. Annals of Clinical and Translational Neurology. 4: 106-118. PMID 28168210 DOI: 10.1002/acn3.384  0.52
2016 Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, ... ... Tabrizi SJ, et al. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease. Human Brain Mapping. PMID 27477323 DOI: 10.1002/hbm.23332  0.4
2016 Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O'Regan A, Queller S, Frost C, Leavitt BR, Dürr A, Roos R, Owen G, Borowsky B, Tabrizi SJ, Stout JC, et al. Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-14. PMID 27211109 DOI: 10.1017/S1355617716000321  0.52
2016 Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 436-57. PMID 27079681 DOI: 10.1002/mds.26527  0.52
2016 Bettencourt C, Moss DH, Flower M, Wiethoff S, Brice A, Goizet C, Stevanin G, Koutsis G, Karadima G, Panas M, Yescas-Gómez P, García-Velázquez LE, Alonso-Vilatela ME, Lima M, Raposo M, ... ... Tabrizi SJ, et al. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Annals of Neurology. PMID 27044000 DOI: 10.1002/ana.24656  0.52
2016 Wiecki TV, Antoniades CA, Stevenson A, Kennard C, Borowsky B, Owen G, Leavitt B, Roos R, Durr A, Tabrizi SJ, Frank MJ. A Computational Cognitive Biomarker for Early-Stage Huntington's Disease. Plos One. 11: e0148409. PMID 26872129 DOI: 10.1371/journal.pone.0148409  0.52
2016 Dobson L, Träger U, Farmer R, Hayardeny L, Loupe P, Hayden MR, Tabrizi SJ. Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells. Journal of Neurochemistry. PMID 26823290 DOI: 10.1111/jnc.13553  0.52
2016 Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, Durr A, Roos RA, Landwehrmeyer GB, Reilmann R, Borowsky B, Stout J, Craufurd D, Tabrizi SJ. Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance. Plos Currents. 8. PMID 26819833 DOI: 10.1371/currents.hd.8060298fac1801b01ccea6acc00f97cb  0.52
2015 Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ. Huntington disease. Nature Reviews. Disease Primers. 1: 15005. PMID 27188817 DOI: 10.1038/nrdp.2015.5  0.36
2015 McCourt AC, Parker J, Silajdžić E, Haider S, Sethi H, Tabrizi SJ, Warner TT, Björkqvist M. Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease. Journal of Huntington's Disease. 4: 371-82. PMID 26756592 DOI: 10.3233/JHD-150172  0.52
2015 Gregory S, Cole JH, Farmer RE, Rees EM, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Zhang H, Scahill RI, Tabrizi SJ, Frost C, Hobbs NZ. Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease. Journal of Huntington's Disease. 4: 333-46. PMID 26756590 DOI: 10.3233/JHD-150173  0.52
2015 McKinnon C, Goold R, Andre R, Devoy A, Ortega Z, Moonga J, Linehan JM, Brandner S, Lucas JJ, Collinge J, Tabrizi SJ. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system. Acta Neuropathologica. PMID 26646779 DOI: 10.1007/s00401-015-1508-y  0.52
2015 Minkova L, Scheller E, Peter J, Abdulkadir A, Kaller CP, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling. Frontiers in Human Neuroscience. 9: 634. PMID 26635585 DOI: 10.3389/fnhum.2015.00634  0.52
2015 Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RA, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, ... ... Tabrizi SJ, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study. Ebiomedicine. 2: 1420-9. PMID 26629536 DOI: 10.1016/j.ebiom.2015.08.002  0.52
2015 Miller JR, Träger U, Andre R, Tabrizi SJ. Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes. Plos One. 10: e0141793. PMID 26529236 DOI: 10.1371/journal.pone.0141793  0.52
2015 Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RA, Reilmann R, Johnson H, Hobbs NZ, Langbehn DR, Stout JC, Tabrizi SJ, Scahill RI. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease. Neuropsychologia. PMID 26519555 DOI: 10.1016/j.neuropsychologia.2015.10.033  0.52
2015 Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington's disease. The Lancet. Neurology. 14: 1135-42. PMID 26466780 DOI: 10.1016/S1474-4422(15)00177-5  0.52
2015 Andre R, Carty L, Tabrizi SJ. Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis. Current Opinion in Pharmacology. 26: 33-38. PMID 26461267 DOI: 10.1016/j.coph.2015.09.008  0.52
2015 Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance. Human Brain Mapping. PMID 26453902 DOI: 10.1002/hbm.23014  0.52
2015 Gregory S, Scahill RI, Seunarine KK, Stopford C, Zhang H, Zhang J, Orth M, Durr A, Roos RA, Langbehn DR, Long JD, Johnson H, Rees G, Tabrizi SJ, Craufurd D. Neuropsychiatry and White Matter Microstructure in Huntington's Disease. Journal of Huntington's Disease. PMID 26443926 DOI: 10.3233/JHD-150160  0.52
2015 McColgan P, Seunarine KK, Razi A, Cole JH, Gregory S, Durr A, Roos RA, Stout JC, Landwehrmeyer B, Scahill RI, Clark CA, Rees G, Tabrizi SJ. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease. Brain : a Journal of Neurology. PMID 26384928 DOI: 10.1093/brain/awv259  0.52
2015 Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers. Neurobiology of Disease. 83: 115-121. PMID 26297319 DOI: 10.1016/j.nbd.2015.08.011  0.52
2015 Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Piccini P, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease. Brain : a Journal of Neurology. 138: 3016-29. PMID 26198591 DOI: 10.1093/brain/awv214  0.52
2015 Bečanović K, Nørremølle A, Neal SJ, Kay C, Collins JA, Arenillas D, Lilja T, Gaudenzi G, Manoharan S, Doty CN, Beck J, Lahiri N, Portales-Casamar E, Warby SC, Connolly C, ... ... Tabrizi SJ, et al. A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease. Nature Neuroscience. 18: 807-16. PMID 25938884 DOI: 10.1038/nn.4014  0.4
2015 Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, Zetterberg H, Leavitt BR, Kuhn R, Tabrizi SJ, Macdonald D, Weiss A. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients. The Journal of Clinical Investigation. 125: 1979-86. PMID 25844897 DOI: 10.1172/JCI80743  0.52
2015 Callaghan J, Stopford C, Arran N, Boisse MF, Coleman A, Santos RD, Dumas EM, Hart EP, Justo D, Owen G, Read J, Say MJ, Durr A, Leavitt BR, Roos RA, ... Tabrizi SJ, et al. Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies. The Journal of Neuropsychiatry and Clinical Neurosciences. 27: 59-64. PMID 25716488 DOI: 10.1176/appi.neuropsych.13070169  0.52
2015 Sturrock A, Laule C, Wyper K, Milner RA, Decolongon J, Dar Santos R, Coleman AJ, Carter K, Creighton S, Bechtel N, Bohlen S, Reilmann R, Johnson HJ, Hayden MR, Tabrizi SJ, et al. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 393-401. PMID 25690257 DOI: 10.1002/mds.26118  0.52
2015 Hobbs NZ, Farmer RE, Rees EM, Cole JH, Haider S, Malone IB, Sprengelmeyer R, Johnson H, Mueller HP, Sussmuth SD, Roos RA, Durr A, Frost C, Scahill RI, Landwehrmeyer B, ... Tabrizi SJ, et al. Short-interval observational data to inform clinical trial design in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25669748 DOI: 10.1136/jnnp-2014-309768  0.52
2015 Novak MJ, Seunarine KK, Gibbard CR, McColgan P, Draganski B, Friston K, Clark CA, Tabrizi SJ. Basal ganglia-cortical structural connectivity in Huntington's disease. Human Brain Mapping. 36: 1728-40. PMID 25640796 DOI: 10.1002/hbm.22733  0.52
2015 Goold R, McKinnon C, Tabrizi SJ. Prion degradation pathways: Potential for therapeutic intervention. Molecular and Cellular Neurosciences. 66: 12-20. PMID 25584786 DOI: 10.1016/j.mcn.2014.12.009  0.52
2015 Süssmuth SD, Haider S, Landwehrmeyer GB, Farmer R, Frost C, Tripepi G, Andersen CA, Di Bacco M, Lamanna C, Diodato E, Massai L, Diamanti D, Mori E, Magnoni L, Dreyhaupt J, ... ... Tabrizi SJ, et al. An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease. British Journal of Clinical Pharmacology. 79: 465-76. PMID 25223731 DOI: 10.1111/bcp.12512  0.52
2015 Ghosh R, Tabrizi SJ. Clinical Aspects of Huntington's Disease. Current Topics in Behavioral Neurosciences. 22: 3-31. PMID 23975844 DOI: 10.1007/7854_2013_238  0.52
2015 Becanovic K, Nørremølle A, Neal SJ, Kay C, Collins JA, Arenillas D, Lilja T, Gaudenzi G, Manoharan S, Doty CN, Beck J, Lahiri N, Portales-Casamar E, Warby SC, Connolly C, ... ... Tabrizi SJ, et al. A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease Nature Neuroscience. 18: 807-816. DOI: 10.1038/nn.4014  0.52
2015 Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RAC, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, ... ... Tabrizi SJ, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study Ebiomedicine. DOI: 10.1016/j.ebiom.2015.08.002  0.52
2015 Tabrizi SJ, Gregory S. Huntington's Disease for Brain Mapping: An Encyclopedic Reference Brain Mapping: An Encyclopedic Reference. 3: 673-682. DOI: 10.1016/B978-0-12-397025-1.00076-2  0.52
2014 Träger U, Andre R, Magnusson-Lind A, Miller JR, Connolly C, Weiss A, Grueninger S, Silajdži? E, Smith DL, Leavitt BR, Bates GP, Björkqvist M, Tabrizi SJ. Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models. Neurobiology of Disease. 73: 388-398. PMID 25447230 DOI: 10.1016/j.nbd.2014.10.012  0.52
2014 Rees EM, Farmer R, Cole JH, Henley SM, Sprengelmeyer R, Frost C, Scahill RI, Hobbs NZ, Tabrizi SJ. Inconsistent emotion recognition deficits across stimulus modalities in Huntington׳s disease. Neuropsychologia. 64: 99-104. PMID 25250707 DOI: 10.1016/j.neuropsychologia.2014.09.023  0.52
2014 Müller HP, Kassubek J, Grön G, Sprengelmeyer R, Ludolph AC, Klöppel S, Hobbs NZ, Roos RA, Duerr A, Tabrizi SJ, Orth M, Süssmuth SD, Landwehrmeyer GB. Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease. Biomedical Engineering Online. 13: 128. PMID 25178314 DOI: 10.1186/1475-925X-13-128  0.52
2014 Wild EJ, Tabrizi SJ. Targets for future clinical trials in Huntington's disease: what's in the pipeline? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1434-45. PMID 25155142 DOI: 10.1002/mds.26007  0.52
2014 Rees EM, Farmer R, Cole JH, Haider S, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Hobbs NZ. Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1648-54. PMID 25123926 DOI: 10.1002/mds.25984  0.52
2014 Jones R, Stout JC, Labuschagne I, Say M, Justo D, Coleman A, Dumas EM, Hart E, Owen G, Durr A, Leavitt BR, Roos R, O'Regan A, Langbehn D, Tabrizi SJ, et al. The potential of composite cognitive scores for tracking progression in Huntington's disease. Journal of Huntington's Disease. 3: 197-207. PMID 25062862 DOI: 10.3233/JHD-140101  0.52
2014 Magnusson-Lind A, Davidsson M, Silajdžić E, Hansen C, McCourt AC, Tabrizi SJ, Björkqvist M. Skeletal muscle atrophy in R6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes. Journal of Huntington's Disease. 3: 13-24. PMID 25062762 DOI: 10.3233/JHD-130075  0.52
2014 Quinn L, Debono K, Dawes H, Rosser AE, Nemeth AH, Rickards H, Tabrizi SJ, Quarrell O, Trender-Gerhard I, Kelson MJ, Townson J, Busse M. Task-specific training in Huntington disease: a randomized controlled feasibility trial. Physical Therapy. 94: 1555-68. PMID 25012999 DOI: 10.2522/ptj.20140123  0.52
2014 Kostro D, Abdulkadir A, Durr A, Roos R, Leavitt BR, Johnson H, Cash D, Tabrizi SJ, Scahill RI, Ronneberger O, Klöppel S. Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing. Neuroimage. 98: 405-15. PMID 24791746 DOI: 10.1016/j.neuroimage.2014.04.057  0.52
2014 Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 673-83. PMID 24757115 DOI: 10.1002/mds.25864  0.52
2014 Andre R, Scahill RI, Haider S, Tabrizi SJ. Biomarker development for Huntington's disease. Drug Discovery Today. 19: 972-9. PMID 24632006 DOI: 10.1016/j.drudis.2014.03.002  0.52
2014 Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology. 10: 204-16. PMID 24614516 DOI: 10.1038/nrneurol.2014.24  0.52
2014 Träger U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A, Grueninger S, McKinnon C, Sirinathsinghji E, Kahlon S, Pfister EL, Moser R, Hummerich H, Antoniou M, Bates GP, Luthi-Carter R, ... ... Tabrizi SJ, et al. HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation. Brain : a Journal of Neurology. 137: 819-33. PMID 24459107 DOI: 10.1093/brain/awt355  0.52
2014 McKinnon C, Tabrizi SJ. The ubiquitin-proteasome system in neurodegeneration. Antioxidants & Redox Signaling. 21: 2302-21. PMID 24437518 DOI: 10.1089/ars.2013.5802  0.52
2014 Smith MR, Syed A, Lukacsovich T, Purcell J, Barbaro BA, Worthge SA, Wei SR, Pollio G, Magnoni L, Scali C, Massai L, Franceschini D, Camarri M, Gianfriddo M, Diodato E, ... ... Tabrizi SJ, et al. A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. Human Molecular Genetics. 23: 2995-3007. PMID 24436303 DOI: 10.1093/hmg/ddu010  0.52
2014 Novak MJ, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 52: 98-112. PMID 24405816 DOI: 10.1016/j.cortex.2013.11.009  0.52
2014 Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, Wild EJ, Sweeney MG, Houlden H, Mead S, Tabrizi SJ. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 82: 292-9. PMID 24363131 DOI: 10.1212/WNL.0000000000000061  0.52
2014 Sprengelmeyer R, Orth M, Müller HP, Wolf RC, Grön G, Depping MS, Kassubek J, Justo D, Rees EM, Haider S, Cole JH, Hobbs NZ, Roos RA, Dürr A, Tabrizi SJ, et al. The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study. Psychological Medicine. 44: 1867-78. PMID 24093462 DOI: 10.1017/S003329171300247X  0.52
2014 Abdulkadir A, Ronneberger O, Tabrizi SJ, Kloppel S. Reduction of confounding effects with voxel-wise Gaussian process regression in structural MRI Proceedings - 2014 International Workshop On Pattern Recognition in Neuroimaging, Prni 2014. DOI: 10.1109/PRNI.2014.6858505  0.52
2014 Rezeli M, Végvári A, Silajdžić E, Björkqvist M, Tabrizi SJ, Laurell T, Marko-Varga G. Inflammatory markers in Huntington's disease plasma-A robust nanoLC-MRM-MS assay development Eupa Open Proteomics. 3: 68-75. DOI: 10.1016/j.euprot.2014.02.003  0.52
2013 Diamanti D, Lahiri N, Tarditi A, Magnoni L, Fondelli C, Morena E, Malusa F, Pollio G, Diodato E, Tripepi G, Tabrizi SJ, Caricasole A, Mori E. Reference genes selection for transcriptional profiling in blood of HD patients and R6/2 mice. Journal of Huntington's Disease. 2: 185-200. PMID 25063515 DOI: 10.3233/JHD-120042  0.52
2013 Read J, Jones R, Owen G, Leavitt BR, Coleman A, Roos RA, Dumas EM, Durr A, Justo D, Say M, Stout JC, Tabrizi SJ, Craufurd D. Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners. Journal of Huntington's Disease. 2: 159-75. PMID 25063513 DOI: 10.3233/JHD-130051  0.52
2013 Silajdžić E, Rezeli M, Végvári Á, Lahiri N, Andre R, Magnusson-Lind A, Nambron R, Kalliolia E, Marko-Varga G, Warner TT, Laurell T, Tabrizi SJ, Björkqvist M. A critical evaluation of inflammatory markers in Huntington's Disease plasma. Journal of Huntington's Disease. 2: 125-34. PMID 25063434 DOI: 10.3233/JHD-130049  0.52
2013 Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, Landwehrmeyer B, Reilmann R, Craufurd D, Stout JC, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Scahill RI, et al. Corpus callosal atrophy in premanifest and early Huntington's disease. Journal of Huntington's Disease. 2: 517-26. PMID 25062736 DOI: 10.3233/JHD-130077  0.52
2013 Massai L, Petricca L, Magnoni L, Rovetini L, Haider S, Andre R, Tabrizi SJ, Süssmuth SD, Landwehrmeyer BG, Caricasole A, Pollio G, Bernocco S. Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells. Bmc Biochemistry. 14: 34. PMID 24274906 DOI: 10.1186/1471-2091-14-34  0.52
2013 Müller HP, Grön G, Sprengelmeyer R, Kassubek J, Ludolph AC, Hobbs N, Cole J, Roos RA, Duerr A, Tabrizi SJ, Landwehrmeyer GB, Süssmuth SD. Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage. Clinical. 2: 161-7. PMID 24179771 DOI: 10.1016/j.nicl.2012.12.005  0.52
2013 Goold R, McKinnon C, Rabbanian S, Collinge J, Schiavo G, Tabrizi SJ. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. Journal of Cell Science. 126: 3552-62. PMID 23813960 DOI: 10.1242/jcs.120477  0.52
2013 Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet. Neurology. 12: 637-49. PMID 23664844 DOI: 10.1016/S1474-4422(13)70088-7  0.52
2013 Borowsky B, Warner J, Leavitt BR, Tabrizi SJ, Roos RA, Durr A, Becker C, Sampaio C, Tobin AJ, Schulman H. 8OHdG is not a biomarker for Huntington disease state or progression. Neurology. 80: 1934-41. PMID 23616162 DOI: 10.1212/WNL.0b013e318293e1a1  0.52
2013 Douglas I, Evans S, Rawlins MD, Smeeth L, Tabrizi SJ, Wexler NS. Juvenile Huntington's disease: a population-based study using the General Practice Research Database. Bmj Open. 3. PMID 23558730 DOI: 10.1136/bmjopen-2012-002085  0.52
2013 Träger U, Tabrizi SJ. Peripheral inflammation in neurodegeneration. Journal of Molecular Medicine (Berlin, Germany). 91: 673-81. PMID 23546523 DOI: 10.1007/s00109-013-1026-0  0.52
2013 Scheller E, Abdulkadir A, Peter J, Tabrizi SJ, Frackowiak RS, Klöppel S. Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. Neuroimage. 75: 146-54. PMID 23501047 DOI: 10.1016/j.neuroimage.2013.02.058  0.52
2013 Evans SJ, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ, Smeeth L. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1156-60. PMID 23482661 DOI: 10.1136/jnnp-2012-304636  0.52
2013 Holl AK, Wilkinson L, Tabrizi SJ, Painold A, Jahanshahi M. Selective executive dysfunction but intact risky decision-making in early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1104-9. PMID 23436289 DOI: 10.1002/mds.25388  0.52
2013 Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, ... ... Tabrizi SJ, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American Journal of Human Genetics. 92: 345-53. PMID 23434116 DOI: 10.1016/j.ajhg.2013.01.011  0.52
2013 Georgiou-Karistianis N, Scahill R, Tabrizi SJ, Squitieri F, Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neuroscience and Biobehavioral Reviews. 37: 480-90. PMID 23376047 DOI: 10.1016/j.neubiorev.2013.01.022  0.52
2013 Labuschagne I, Jones R, Callaghan J, Whitehead D, Dumas EM, Say MJ, Hart EP, Justo D, Coleman A, Dar Santos RC, Frost C, Craufurd D, Tabrizi SJ, Stout JC. Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease. Psychiatry Research. 207: 118-26. PMID 23051887 DOI: 10.1016/j.psychres.2012.09.022  0.52
2013 van den Bogaard SJ, Dumas EM, Hart EP, Milles J, Reilmann R, Stout JC, Craufurd D, Gibbard CR, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up. Ajnr. American Journal of Neuroradiology. 34: 317-22. PMID 22918430 DOI: 10.3174/ajnr.A3303  0.52
2013 Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S. The structural correlates of functional deficits in early huntington's disease. Human Brain Mapping. 34: 2141-53. PMID 22438242 DOI: 10.1002/hbm.22055  0.52
2013 Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, ... ... Tabrizi SJ, et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Human Brain Mapping. 34: 519-29. PMID 22102212 DOI: 10.1002/hbm.21449  0.52
2012 Dumas EM, Say MJ, Jones R, Labuschagne I, O'Regan AM, Hart EP, van den Bogaard SJ, Queller S, Justo D, Coleman A, Dar Santos RC, Dürr A, Leavitt BR, Tabrizi SJ, Roos RA, et al. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. Journal of Huntington's Disease. 1: 97-106. PMID 25063192 DOI: 10.3233/JHD-2012-120010  0.52
2012 Hobbs NZ, Cole JH, Farmer RE, Rees EM, Crawford HE, Malone IB, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Frost C. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study. Neuroimage. Clinical. 2: 204-11. PMID 24179770 DOI: 10.1016/j.nicl.2012.12.001  0.52
2012 Scahill RI, Wild EJ, Tabrizi SJ. Biomarkers for Huntington's disease: an update. Expert Opinion On Medical Diagnostics. 6: 371-5. PMID 23480802 DOI: 10.1517/17530059.2012.701205  0.52
2012 Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S, Moussaoui S, Tabrizi SJ, Stella N, Muchowski PJ. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 18259-68. PMID 23238740 DOI: 10.1523/JNEUROSCI.4008-12.2012  0.52
2012 Kwan W, Träger U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C, Möller T, Stella N, Akassoglou K, Tabrizi SJ, Muchowski PJ. Mutant huntingtin impairs immune cell migration in Huntington disease. The Journal of Clinical Investigation. 122: 4737-47. PMID 23160193 DOI: 10.1172/JCI64484  0.52
2012 Weiss A, Träger U, Wild EJ, Grueninger S, Farmer R, Landles C, Scahill RI, Lahiri N, Haider S, Macdonald D, Frost C, Bates GP, Bilbe G, Kuhn R, Andre R, ... Tabrizi SJ, et al. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. The Journal of Clinical Investigation. 122: 3731-6. PMID 22996692 DOI: 10.1172/JCI64565  0.52
2012 Holl AK, Wilkinson L, Tabrizi SJ, Painold A, Jahanshahi M. Probabilistic classification learning with corrective feedback is selectively impaired in early Huntington's disease--evidence for the role of the striatum in learning with feedback. Neuropsychologia. 50: 2176-86. PMID 22659110 DOI: 10.1016/j.neuropsychologia.2012.05.021  0.52
2012 Stout JC, Jones R, Labuschagne I, O'Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Dürr A, Leavitt BR, Roos RA, Langbehn DR, ... Tabrizi SJ, et al. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 687-94. PMID 22566599 DOI: 10.1136/jnnp-2011-301940  0.52
2012 Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ. Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain : a Journal of Neurology. 135: 1165-79. PMID 22505631 DOI: 10.1093/brain/aws024  0.52
2012 Andre R, Tabrizi SJ. Misfolded PrP and a novel mechanism of proteasome inhibition. Prion. 6: 32-6. PMID 22453175 DOI: 10.4161/pri.6.1.18272  0.52
2012 Andre R, Wild EJ, Tabrizi SJ. Huntington's disease: fighting on many fronts. Brain : a Journal of Neurology. 135: 998-1001. PMID 22427330 DOI: 10.1093/brain/aws060  0.52
2012 Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, Scahill RI, Tabrizi SJ, Ourselin S, Fox NC, Alexander DC. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage. 60: 1880-9. PMID 22281676 DOI: 10.1016/j.neuroimage.2012.01.062  0.52
2012 Kwan W, Magnusson A, Chou A, Adame A, Carson MJ, Kohsaka S, Masliah E, Möller T, Ransohoff R, Tabrizi SJ, Björkqvist M, Muchowski PJ. Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 133-42. PMID 22219276 DOI: 10.1523/JNEUROSCI.4846-11.2012  0.52
2012 Olsson MG, Davidsson S, Muhammad ZD, Lahiri N, Tabrizi SJ, Akerstrom B, Bjorkqvist M. Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease. Frontiers in Bioscience (Elite Edition). 4: 950-7. PMID 22201927  0.52
2012 Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet. Neurology. 11: 42-53. PMID 22137354 DOI: 10.1016/S1474-4422(11)70263-0  0.52
2012 Henley SM, Novak MJ, Frost C, King J, Tabrizi SJ, Warren JD. Emotion recognition in Huntington's disease: a systematic review. Neuroscience and Biobehavioral Reviews. 36: 237-53. PMID 21699916 DOI: 10.1016/j.neubiorev.2011.06.002  0.52
2012 Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Human Brain Mapping. 33: 203-12. PMID 21264990 DOI: 10.1002/hbm.21205  0.52
2012 Wild EJ, Tabrizi SJ. Huntington’s disease Neurogenetics: a Guide For Clinicians. 64-82. DOI: 10.1017/CBO9781139087711.006  0.52
2011 Müller HP, Süssmuth SD, Landwehrmeyer GB, Ludolph A, Tabrizi SJ, Kloppel S, Kassubek J. Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease. Plos Currents. 3: RRN1292. PMID 22307262 DOI: 10.1371/currents.RRN1292  0.52
2011 Novak MJ, Tabrizi SJ. A man with deteriorating ability to live independently. Bmj (Clinical Research Ed.). 343: d7463. PMID 22115904 DOI: 10.1136/bmj.d7463  0.52
2011 Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D, Arning L. NMDA receptor gene variations as modifiers in Huntington disease: a replication study. Plos Currents. 3: RRN1247. PMID 21989477 DOI: 10.1371/currents.RRN1247  0.52
2011 Novak MJ, Tabrizi SJ. Huntington's disease: clinical presentation and treatment. International Review of Neurobiology. 98: 297-323. PMID 21907093 DOI: 10.1016/B978-0-12-381328-2.00013-4  0.52
2011 Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E. Brain-derived neurotrophic factor in patients with Huntington's disease. Plos One. 6: e22966. PMID 21857974 DOI: 10.1371/journal.pone.0022966  0.52
2011 Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, Björkqvist M. Abnormal peripheral chemokine profile in Huntington's disease. Plos Currents. 3: RRN1231. PMID 21826115 DOI: 10.1371/currents.RRN1231  0.52
2011 Deriziotis P, André R, Smith DM, Goold R, Kinghorn KJ, Kristiansen M, Nathan JA, Rosenzweig R, Krutauz D, Glickman MH, Collinge J, Goldberg AL, Tabrizi SJ. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. The Embo Journal. 30: 3065-77. PMID 21743439 DOI: 10.1038/emboj.2011.224  0.52
2011 Müller HP, Glauche V, Novak MJ, Nguyen-Thanh T, Unrath A, Lahiri N, Read J, Say MJ, Tabrizi SJ, Kassubek J, Kloppel S. Stability of white matter changes related to Huntington's disease in the presence of imaging noise: a DTI study. Plos Currents. 3: RRN1232. PMID 21686312 DOI: 10.1371/currents.RRN1232  0.52
2011 Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1684-90. PMID 21557312 DOI: 10.1002/mds.23747  0.52
2011 Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, Tabrizi SJ. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nature Communications. 2: 281. PMID 21505437 DOI: 10.1038/ncomms1282  0.52
2011 Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Björkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Human Molecular Genetics. 20: 2225-37. PMID 21421997 DOI: 10.1093/hmg/ddr111  0.52
2011 Munsie L, Caron N, Atwal RS, Marsden I, Wild EJ, Bamburg JR, Tabrizi SJ, Truant R. Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease. Human Molecular Genetics. 20: 1937-51. PMID 21355047 DOI: 10.1093/hmg/ddr075  0.52
2011 Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Human Brain Mapping. 32: 258-70. PMID 21229614 DOI: 10.1002/hbm.21008  0.52
2011 Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. The Lancet. Neurology. 10: 83-98. PMID 21163446 DOI: 10.1016/S1474-4422(10)70245-3  0.52
2011 Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet. Neurology. 10: 31-42. PMID 21130037 DOI: 10.1016/S1474-4422(10)70276-3  0.52
2011 Orth M, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1409-12. PMID 21097549 DOI: 10.1136/jnnp.2010.209668  0.52
2011 Say MJ, Jones R, Scahill RI, Dumas EM, Coleman A, Santos RC, Justo D, Campbell JC, Queller S, Shores EA, Tabrizi SJ, Stout JC. Visuomotor integration deficits precede clinical onset in Huntington's disease. Neuropsychologia. 49: 264-70. PMID 21094653 DOI: 10.1016/j.neuropsychologia.2010.11.016  0.52
2011 van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. Journal of Neurology. 258: 412-20. PMID 20936300 DOI: 10.1007/s00415-010-5768-0  0.52
2011 Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, et al. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 207-17. PMID 20500522 DOI: 10.1111/j.1468-1331.2010.03069.x  0.52
2011 Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, et al. Molecular Diagnosis of Neurogenetic Disorders: Motoneuron, Peripheral Nerve and Muscle Disorders European Handbook of Neurological Management. 2: 97-109. DOI: 10.1002/9781444346268.ch8  0.52
2011 Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, et al. Molecular Diagnosis of Channelopathies, Epilepsies, Migraine, Stroke and Dementias European Handbook of Neurological Management. 2: 87-96. DOI: 10.1002/9781444346268.ch7  0.52
2011 Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CME, et al. Molecular Diagnosis of Ataxias and Spastic Paraplegias European Handbook of Neurological Management. 2: 73-85. DOI: 10.1002/9781444346268.ch6  0.52
2011 Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, et al. Molecular Diagnosis of Mitochondrial Disorders European Handbook of Neurological Management. 2: 61-72. DOI: 10.1002/9781444346268.ch5  0.52
2011 Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, et al. Molecular Diagnosis of Neurogenetic Disorders: General Issues, Huntington's Disease, Parkinson's Disease and Dystonias European Handbook of Neurological Management. 2: 51-60. DOI: 10.1002/9781444346268.ch4  0.52
2010 Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, ... ... Tabrizi SJ, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 75: 2150-60. PMID 21068430 DOI: 10.1212/WNL.0b013e3182020123  0.52
2010 Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 75: 1702-10. PMID 21060093 DOI: 10.1212/WNL.0b013e3181fc27e4  0.52
2010 Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. Plos Currents. 2: RRN1184. PMID 20890398 DOI: 10.1371/currents.RRN1184  0.52
2010 Novak MJ, Sweeney MG, Li A, Treacy C, Chandrashekar HS, Giunti P, Goold RG, Davis MB, Houlden H, Tabrizi SJ. An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2176-82. PMID 20669319 DOI: 10.1002/mds.23223  0.52
2010 Novak MJ, Tabrizi SJ. Huntington's disease. Bmj (Clinical Research Ed.). 340: c3109. PMID 20591965 DOI: 10.1136/bmj.c3109  0.52
2010 Schneider SA, Wilkinson L, Bhatia KP, Henley SM, Rothwell JC, Tabrizi SJ, Jahanshahi M. Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1343-9. PMID 20544716 DOI: 10.1002/mds.22692  0.52
2010 Ahmed Z, Tabrizi SJ, Li A, Houlden H, Sailer A, Lees AJ, Revesz T, Holton JL. A Huntington's disease phenocopy characterized by pallido-nigro-luysian degeneration with brain iron accumulation and p62-positive glial inclusions. Neuropathology and Applied Neurobiology. 36: 551-7. PMID 20497339 DOI: 10.1111/j.1365-2990.2010.01093.x  0.52
2010 Wild EJ, Henley SM, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 888-95. PMID 20461806 DOI: 10.1002/mds.22969  0.52
2010 Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, et al. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 641-8. PMID 20298421 DOI: 10.1111/j.1468-1331.2010.02985.x  0.52
2010 Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. Ajnr. American Journal of Neuroradiology. 31: 1036-41. PMID 20150305 DOI: 10.3174/ajnr.A2018  0.52
2010 Marullo M, Zuccato C, Mariotti C, Lahiri N, Tabrizi SJ, Di Donato S, Cattaneo E. Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data. Genome Biology. 11: R9. PMID 20109193 DOI: 10.1186/gb-2010-11-1-r9  0.52
2010 Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, et al. EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 179-88. PMID 20050888 DOI: 10.1111/j.1468-1331.2009.02873.x  0.52
2010 Henley SM, Ridgway GR, Scahill RI, Klöppel S, Tabrizi SJ, Fox NC, Kassubek J. Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. Ajnr. American Journal of Neuroradiology. 31: 711-9. PMID 20037137 DOI: 10.3174/ajnr.A1939  0.52
2010 Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 756-63. PMID 19955112 DOI: 10.1136/jnnp.2009.190702  0.52
2010 Klöppel S, Stonnington CM, Petrovic P, Mobbs D, Tüscher O, Craufurd D, Tabrizi SJ, Frackowiak RS. Irritability in pre-clinical Huntington's disease. Neuropsychologia. 48: 549-57. PMID 19878688 DOI: 10.1016/j.neuropsychologia.2009.10.016  0.52
2010 Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P. Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers. Neurobiology of Disease. 37: 356-61. PMID 19853661 DOI: 10.1016/j.nbd.2009.10.015  0.52
2010 Orth M, Schippling S, Schneider SA, Bhatia KP, Talelli P, Tabrizi SJ, Rothwell JC. Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 267-70. PMID 19828482 DOI: 10.1136/jnnp.2009.171926  0.52
2009 Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, et al. EFNS guidelines on the molecular diagnosis of mitochondrial disorders. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 1255-64. PMID 19950421 DOI: 10.1111/j.1468-1331.2009.02811.x  0.52
2009 Björkqvist M, Wild EJ, Tabrizi SJ. Harnessing immune alterations in neurodegenerative diseases. Neuron. 64: 21-4. PMID 19840543 DOI: 10.1016/j.neuron.2009.09.034  0.52
2009 Lahiri N, Tabrizi SJ. Huntington disease: a tale of two genes. Neurology. 73: 1254-5. PMID 19776377 DOI: 10.1212/WNL.0b013e3181beed15  0.52
2009 Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology. 8: 791-801. PMID 19646924 DOI: 10.1016/S1474-4422(09)70170-X  0.52
2009 Robert MP, Nachev PC, Hicks SL, Golding CV, Tabrizi SJ, Kennard C. Saccadometry of conditional rules in presymptomatic Huntington's disease. Annals of the New York Academy of Sciences. 1164: 444-50. PMID 19645945 DOI: 10.1111/j.1749-6632.2008.03736.x  0.52
2009 Hobbs NZ, Henley SM, Wild EJ, Leung KK, Frost C, Barker RA, Scahill RI, Barnes J, Tabrizi SJ, Fox NC. Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease. Neuroimage. 47: 1659-65. PMID 19523522 DOI: 10.1016/j.neuroimage.2009.06.003  0.52
2009 Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, et al. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 777-85. PMID 19469830 DOI: 10.1111/j.1468-1331.2009.02646.x  0.52
2009 Klöppel S, Henley SM, Hobbs NZ, Wolf RC, Kassubek J, Tabrizi SJ, Frackowiak RS. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience. 164: 205-19. PMID 19409230 DOI: 10.1016/j.neuroscience.2009.01.045  0.52
2009 Klöppel S, Draganski B, Siebner HR, Tabrizi SJ, Weiller C, Frackowiak RS. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain : a Journal of Neurology. 132: 1624-32. PMID 19369489 DOI: 10.1093/brain/awp081  0.52
2009 Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, Abramov AY. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Molecular Cell. 33: 627-38. PMID 19285945 DOI: 10.1016/j.molcel.2009.02.013  0.52
2009 Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. Journal of Neurology. 256: 203-12. PMID 19266143 DOI: 10.1007/s00415-009-0052-x  0.52
2009 Henley SM, Wild EJ, Hobbs NZ, Frost C, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 932-6. PMID 19243073 DOI: 10.1002/mds.22485  0.52
2009 Schippling S, Schneider SA, Bhatia KP, Münchau A, Rothwell JC, Tabrizi SJ, Orth M. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biological Psychiatry. 65: 959-65. PMID 19200948 DOI: 10.1016/j.biopsych.2008.12.026  0.52
2009 Klöppel S, Chu C, Tan GC, Draganski B, Johnson H, Paulsen JS, Kienzle W, Tabrizi SJ, Ashburner J, Frackowiak RS. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology. 72: 426-31. PMID 19188573 DOI: 10.1212/01.wnl.0000341768.28646.b6  0.52
2009 Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TE, Campbell T, Adamson G, Deriziotis P, Tabrizi SJ, Hummerich H, Verzilli C, Alpers MP, Whittaker JC, Collinge J. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. The Lancet. Neurology. 8: 57-66. PMID 19081515 DOI: 10.1016/S1474-4422(08)70265-5  0.52
2008 Wild EJ, Tabrizi SJ. Biomarkers for Huntington's disease. Expert Opinion On Medical Diagnostics. 2: 47-62. PMID 23485116 DOI: 10.1517/17530059.2.1.47  0.52
2008 Wild E, Björkqvist M, Tabrizi SJ. Immune markers for Huntington's disease? Expert Review of Neurotherapeutics. 8: 1779-81. PMID 19086873 DOI: 10.1586/14737175.8.12.1779  0.52
2008 Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain : a Journal of Neurology. 131: 2860-9. PMID 18829696 DOI: 10.1093/brain/awn244  0.52
2008 Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Björkhem I, Cattaneo E, Di Donato S. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain : a Journal of Neurology. 131: 2851-9. PMID 18772220 DOI: 10.1093/brain/awn212  0.52
2008 Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C. Oculomotor deficits indicate the progression of Huntington's disease. Progress in Brain Research. 171: 555-8. PMID 18718352 DOI: 10.1016/S0079-6123(08)00678-X  0.52
2008 Deriziotis P, Tabrizi SJ. Prions and the proteasome. Biochimica Et Biophysica Acta. 1782: 713-22. PMID 18644436 DOI: 10.1016/j.bbadis.2008.06.011  0.52
2008 Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, ... ... Tabrizi SJ, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. The Journal of Experimental Medicine. 205: 1869-77. PMID 18625748 DOI: 10.1084/jem.20080178  0.52
2008 Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AY, Abramov AS, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, ... ... Tabrizi SJ, et al. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. Plos One. 3: e2455. PMID 18560593 DOI: 10.1371/journal.pone.0002455  0.52
2008 Henley SM, Wild EJ, Hobbs NZ, Warren JD, Frost C, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia. 46: 2152-60. PMID 18407301 DOI: 10.1016/j.neuropsychologia.2008.02.025  0.52
2008 Wood NI, Goodman AO, van der Burg JM, Gazeau V, Brundin P, Björkqvist M, Petersén A, Tabrizi SJ, Barker RA, Morton AJ. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Research Bulletin. 76: 70-9. PMID 18395613 DOI: 10.1016/j.brainresbull.2007.12.007  0.52
2008 Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ. Huntington's disease phenocopies are clinically and genetically heterogeneous. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 716-20. PMID 18181206 DOI: 10.1002/mds.21915  0.52
2008 Klöppel S, Draganski B, Golding CV, Chu C, Nagy Z, Cook PA, Hicks SL, Kennard C, Alexander DC, Parker GJ, Tabrizi SJ, Frackowiak RS. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain : a Journal of Neurology. 131: 196-204. PMID 18056161 DOI: 10.1093/brain/awm275  0.52
2007 Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Practical Neurology. 7: 360-73. PMID 18024776 DOI: 10.1136/pn.2007.134585  0.52
2007 Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Current Opinion in Neurology. 20: 681-7. PMID 17992089 DOI: 10.1097/WCO.0b013e3282f12074  0.52
2007 Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, Régulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R. Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proceedings of the National Academy of Sciences of the United States of America. 104: 14424-9. PMID 17724341 DOI: 10.1073/pnas.0703652104  0.52
2007 Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Björkqvist M, Petersén A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, Leavitt BR, Keir G, Ward M, Tabrizi SJ. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. Journal of Proteome Research. 6: 2833-40. PMID 17552550 DOI: 10.1021/pr0700753  0.52
2007 Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menéndez-Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ. Disease-associated prion protein oligomers inhibit the 26S proteasome. Molecular Cell. 26: 175-88. PMID 17466621 DOI: 10.1016/j.molcel.2007.04.001  0.52
2007 Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain : a Journal of Neurology. 130: 1759-66. PMID 17400599 DOI: 10.1093/brain/awm044  0.52
2007 Wild EJ, Petzold A, Keir G, Tabrizi SJ. Plasma neurofilament heavy chain levels in Huntington's disease. Neuroscience Letters. 417: 231-3. PMID 17363167 DOI: 10.1016/j.neulet.2007.02.053  0.52
2007 Zourlidou A, Gidalevitz T, Kristiansen M, Landles C, Woodman B, Wells DJ, Latchman DS, de Belleroche J, Tabrizi SJ, Morimoto RI, Bates GP. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Human Molecular Genetics. 16: 1078-90. PMID 17360721 DOI: 10.1093/hmg/ddm057  0.52
2007 Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Imaging microglial activation in Huntington's disease. Brain Research Bulletin. 72: 148-51. PMID 17352938 DOI: 10.1016/j.brainresbull.2006.10.029  0.52
2006 Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain : a Journal of Neurology. 129: 3042-50. PMID 17071923 DOI: 10.1093/brain/awl279  0.52
2006 Henley SM, Frost C, MacManus DG, Warner TT, Fox NC, Tabrizi SJ. Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology. 67: 694-6. PMID 16924028 DOI: 10.1212/01.wnl.0000230149.36635.c8  0.52
2006 Wild EJ, Tabrizi SJ. Predict-HD and the future of therapeutic trials. The Lancet. Neurology. 5: 724-5. PMID 16914400 DOI: 10.1016/S1474-4422(06)70531-2  0.52
2006 Holmes E, Tsang TM, Tabrizi SJ. The application of NMR-based metabonomics in neurological disorders. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 358-72. PMID 16815219 DOI: 10.1016/j.nurx.2006.05.004  0.52
2006 Golding CV, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. 67: 485-7. PMID 16625001 DOI: 10.1212/01.wnl.0000218215.43328.88  0.52
2006 Björkqvist M, Petersén A, Bacos K, Isaacs J, Norlén P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P, Mulder H. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Human Molecular Genetics. 15: 1713-21. PMID 16613897 DOI: 10.1093/hmg/ddl094  0.52
2006 Tsang TM, Woodman B, McLoughlin GA, Griffin JL, Tabrizi SJ, Bates GP, Holmes E. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. Journal of Proteome Research. 5: 483-92. PMID 16512662 DOI: 10.1021/pr050244o  0.52
Show low-probability matches.